CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 42.86%

Compliant submissions 3

Incompliant submissions 4

Total trials 7

My Organizations' Clinical Trials

Showing 575 of 2008 entries

View as:

Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients

Phase: N/A Priority: Normal

NCT ID: NCT02451462 Org: User:

Start: 09/30/15 End: 09/30/18 Due: 09/30/19

Efficacy of a Structured Weight Loss Program in Overweight Women With a History of Recurrent Pregnancy Loss

Phase: N/A Priority: Normal

NCT ID: NCT01325805 Org: User:

Start: 12/31/10 End: 12/31/13 Due: 12/31/14

Genetics of Recurrent Early Onset Major Depression

Phase: N/A Priority: Normal

NCT ID: NCT00260182 Org: User:

Start: 10/31/05 End: 06/30/09 Due: 06/30/10

Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes

Phase: N/A Priority: Normal

NCT ID: NCT01186276 Org: User:

Start: 07/31/10 End: 09/30/15 Due: 09/30/16

Effectiveness of Family-Based Versus Individual Psychotherapy in Treating Adolescents With Anorexia Nervosa

Phase: N/A Priority: Normal

NCT ID: NCT00149786 Org: User:

Start: 10/31/04 End: 03/31/09 Due: 03/31/10

Integrating the Genetic and Metabolic Faces of Obesity

Phase: N/A Priority: Normal

NCT ID: NCT00285844 Org: User:

Start: 10/31/05 End: 10/31/12 Due: 10/31/13

68-Ga-FAPI PET Imaging in Malignancy

Phase: N/A Priority: Normal

NCT ID: NCT04023240 Org: User:

Start: 07/31/23 End: 12/14/23 Due: 12/14/24

Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1

Phase: N/A Priority: Normal

NCT ID: NCT02485080 Org: User:

Start: 09/30/15 End: 01/31/16 Due: 01/31/17

Evaluation of Stereotactic Radiosurgery For Liver Malignancies

Phase: N/A Priority: Normal

NCT ID: NCT00230347 Org: User:

Start: 10/31/03 End: 02/28/07 Due: 02/28/08

Heart Disease on the Mend

Phase: N/A Priority: Normal

NCT ID: NCT00127751 Org: User:

Start: 05/31/00 End: 05/31/03 Due: 05/31/04

Measured Hypocretin Levels and Recovery After Hip Surgery

Phase: N/A Priority: Normal

NCT ID: NCT01009710 Org: User:

Start: 07/31/09 End: 12/31/18 Due: 12/31/19

SAINT for Treatment of Preoperative Depression to Reduce Opioid Use Following Arthroplasty

Phase: N/A Priority: Normal

NCT ID: NCT04195308 Org: User:

Start: 06/30/24 End: 11/30/26 Due: 11/30/27

Stanford Healthy Heart Study

Phase: N/A Priority: Normal

NCT ID: NCT03014414 Org: User:

Start: 03/04/17 End: 01/27/22 Due: 01/27/23

Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00481845 Org: User:

Start: 01/31/08 End: 12/31/09 Due: 12/31/10

Exenatide and Weight Loss for Diabetes Prevention

Phase: N/A Priority: Normal

NCT ID: NCT02084654 Org: User:

Start: 11/30/07 End: 02/28/13 Due: 02/28/14

Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin

Phase: N/A Priority: Normal

NCT ID: NCT01322386 Org: User:

Start: 05/31/07 End: 01/31/12 Due: 01/31/13

Virtual Hypertension Management Pilot

Phase: N/A Priority: Normal

NCT ID: NCT03291535 Org: User:

Start: 07/26/17 End: 03/01/22 Due: 03/01/23

Electrical Stimulation as an Adjunctive Therapy to Increase Vascular Perfusion in People With PAD or PVD

Phase: N/A Priority: Normal

NCT ID: NCT04313985 Org: User:

Start: 08/01/19 End: 03/31/22 Due: 03/31/23

Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00780988 Org: User:

Start: - End: - Due: -

Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease

Phase: N/A Priority: Normal

NCT ID: NCT00388349 Org: User:

Start: 09/30/01 End: 09/30/10 Due: 09/30/11

Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT03201068 Org: User:

Start: 09/14/17 End: 12/04/18 Due: 12/04/19

Imaging and Biomarkers of Hypoxia in Solid Tumors

Phase: N/A Priority: Normal

NCT ID: NCT01123005 Org: User:

Start: 12/31/10 End: 08/21/15 Due: 08/21/16

Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia

Phase: N/A Priority: Normal

NCT ID: NCT00160329 Org: User:

Start: 01/31/04 End: 03/31/09 Due: 03/31/10

Designing Food Voucher Programs to Reduce Disparities in Healthy Diets

Phase: N/A Priority: Normal

NCT ID: NCT02843178 Org: User:

Start: 12/31/16 End: 10/09/18 Due: 10/09/19

Radical-Dose Image Guided Radiation Therapy in Treating Patients With Metastatic Non-small Cell Lung Cancer Undergoing Immunotherapy

Phase: N/A Priority: Normal

NCT ID: NCT03176173 Org: User:

Start: 06/28/17 End: 05/01/26 Due: 05/01/27

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients	NCT02451462	Stanford University	user2@example.com	None	2015-09-30	2018-09-30	2019-09-30	-	-	2025-07-14
Efficacy of a Structured Weight Loss Program in Overweight Women With a History of Recurrent Pregnancy Loss	NCT01325805	Stanford University	user2@example.com	None	2010-12-31	2013-12-31	2014-12-31	-	-	2025-07-14
Genetics of Recurrent Early Onset Major Depression	NCT00260182	Stanford University	user2@example.com	None	2005-10-31	2009-06-30	2010-06-30	-	-	2025-07-14
Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes	NCT01186276	Stanford University	user2@example.com	None	2010-07-31	2015-09-30	2016-09-30	-	-	2025-07-14
Effectiveness of Family-Based Versus Individual Psychotherapy in Treating Adolescents With Anorexia Nervosa	NCT00149786	Stanford University	user2@example.com	None	2004-10-31	2009-03-31	2010-03-31	-	-	2025-07-14
Integrating the Genetic and Metabolic Faces of Obesity	NCT00285844	Stanford University	user2@example.com	None	2005-10-31	2012-10-31	2013-10-31	-	-	2025-07-14
68-Ga-FAPI PET Imaging in Malignancy	NCT04023240	Stanford University	user2@example.com	None	2023-07-31	2023-12-14	2024-12-14	-	-	2025-07-14
Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1	NCT02485080	Stanford University	user2@example.com	None	2015-09-30	2016-01-31	2017-01-31	-	-	2025-07-14
Evaluation of Stereotactic Radiosurgery For Liver Malignancies	NCT00230347	Stanford University	user2@example.com	None	2003-10-31	2007-02-28	2008-02-28	-	-	2025-07-14
Heart Disease on the Mend	NCT00127751	Stanford University	user2@example.com	None	2000-05-31	2003-05-31	2004-05-31	-	-	2025-07-14
Measured Hypocretin Levels and Recovery After Hip Surgery	NCT01009710	Stanford University	user2@example.com	None	2009-07-31	2018-12-31	2019-12-31	-	-	2025-07-14
SAINT for Treatment of Preoperative Depression to Reduce Opioid Use Following Arthroplasty	NCT04195308	Stanford University	user2@example.com	None	2024-06-30	2026-11-30	2027-11-30	-	-	2025-07-14
Stanford Healthy Heart Study	NCT03014414	Stanford University	user2@example.com	None	2017-03-04	2022-01-27	2023-01-27	-	-	2025-07-14
Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer	NCT00481845	Stanford University	user2@example.com	None	2008-01-31	2009-12-31	2010-12-31	-	-	2025-07-14
Exenatide and Weight Loss for Diabetes Prevention	NCT02084654	Stanford University	user2@example.com	None	2007-11-30	2013-02-28	2014-02-28	-	-	2025-07-14
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin	NCT01322386	Stanford University	user2@example.com	None	2007-05-31	2012-01-31	2013-01-31	-	-	2025-07-14
Virtual Hypertension Management Pilot	NCT03291535	Stanford University	user2@example.com	None	2017-07-26	2022-03-01	2023-03-01	-	-	2025-07-14
Electrical Stimulation as an Adjunctive Therapy to Increase Vascular Perfusion in People With PAD or PVD	NCT04313985	Stanford University	user2@example.com	None	2019-08-01	2022-03-31	2023-03-31	-	-	2025-07-14
Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer	NCT00780988	Stanford University	user2@example.com	None	-	-	-	-	-	2025-07-14
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease	NCT00388349	Stanford University	user2@example.com	None	2001-09-30	2010-09-30	2011-09-30	-	-	2025-07-14
Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome	NCT03201068	Stanford University	user2@example.com	None	2017-09-14	2018-12-04	2019-12-04	-	-	2025-07-14
Imaging and Biomarkers of Hypoxia in Solid Tumors	NCT01123005	Stanford University	user2@example.com	None	2010-12-31	2015-08-21	2016-08-21	-	-	2025-07-14
Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia	NCT00160329	Stanford University	user2@example.com	None	2004-01-31	2009-03-31	2010-03-31	-	-	2025-07-14
Designing Food Voucher Programs to Reduce Disparities in Healthy Diets	NCT02843178	Stanford University	user2@example.com	None	2016-12-31	2018-10-09	2019-10-09	-	-	2025-07-14
Radical-Dose Image Guided Radiation Therapy in Treating Patients With Metastatic Non-small Cell Lung Cancer Undergoing Immunotherapy	NCT03176173	Stanford University	user2@example.com	None	2017-06-28	2026-05-01	2027-05-01	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance